dc.contributorUniversidade de São Paulo (USP)
dc.contributorUniversidade Federal de Minas Gerais (UFMG)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:28:48Z
dc.date.available2014-05-27T11:28:48Z
dc.date.created2014-05-27T11:28:48Z
dc.date.issued2013-04-01
dc.identifierRevista Brasileira de Psiquiatria, v. 35, n. 2, p. 178-185, 2013.
dc.identifier1516-4446
dc.identifierhttp://hdl.handle.net/11449/74996
dc.identifier10.1590/1516-4446-2012-3503
dc.identifierS1516-4446-2012-3503
dc.identifierWOS:000322543200014
dc.identifier2-s2.0-84880978505
dc.identifier2-s2.0-84880978505.pdf
dc.identifier7964386240653380
dc.description.abstractObjective: To critically review and evaluate existing knowledge on the conceptual limits and clinical usefulness of the diagnosis of mild cognitive impairment (MCI) and the neuropsychological assessment and short- and long-term prognosis thereof. Methods: We conducted a systematic search of the PubMed and Web of Science electronic databases, limited to articles published in English between 1999 and 2012. Based on the search terms mild cognitive impairment or MCI and epidemiology or diagnosis, we retrieved 1,698 articles, of which 248 were critically eligible (cross-sectional and longitudinal studies); the abstracts of the remaining 1,450 articles were also reviewed. Results: A critical review on the MCI construct is provided, including conceptual and diagnostic aspects; epidemiological relevance; clinical assessment; prognosis; and outcome. The distinct definitions of cognitive impairment, MCI included, yield clinically heterogeneous groups of individuals. Those who will eventually progress to dementia may present with symptoms consistent with the definition of MCI; conversely, individuals with MCI may remain stable or return to normal cognitive function. Conclusion: On clinical grounds, the cross-sectional diagnosis of MCI has limited prognostic relevance. The characterization of persistent and/or progressive cognitive deficits over time is a better approach for identification of cases at the pre-dementia stages, particularly if these cognitive abnormalities are consistent with the natural history of incipient Alzheimer's disease. © 2013 Associação Brasileira de Psiquiatria.
dc.languageeng
dc.relationRevista Brasileira de Psiquiatria
dc.relation2.093
dc.relation0,803
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectAlzheimer's disease
dc.subjectBiomarkers
dc.subjectDementia
dc.subjectMild cognitive impairment
dc.subjectbiological marker
dc.subjectAlzheimer disease
dc.subjectbibliographic database
dc.subjectclinical assessment
dc.subjectclinical feature
dc.subjectdementia
dc.subjecthuman
dc.subjectinformation processing
dc.subjectmemory
dc.subjectmild cognitive impairment
dc.subjectMini Mental State Examination
dc.subjectneuropsychiatry
dc.subjectoutcome assessment
dc.subjectprognosis
dc.subjectpsychologic assessment
dc.subjectrisk
dc.subjectscoring system
dc.titleMild cognitive impairment (part 1): Clinical characteristics and predictors of dementia
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución